Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2012
06/28/2012US20120165358 Controlled release formulations of opioid and nonopioid analgesics
06/28/2012US20120165302 Antifungal formulations
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165255 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
06/28/2012US20120165252 Method of Regulating Glucose Metabolism, and Reagents Related Thereto
06/28/2012US20120164265 Dietary Method for Modulating Glucose Metabolism
06/28/2012US20120164221 Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night
06/28/2012US20120164124 Phage-associated lytic enzymes for treatment of bacillus anthracis and related conditions
06/28/2012US20120164122 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases
06/28/2012CA2822723A1 Modulators of trpa1 for the treatment of rosacea
06/28/2012CA2822553A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
06/27/2012EP2468299A2 Compositions for inducing immune responses
06/27/2012EP2468273A2 Method to reduce oxidative damage and improve mitochondrial efficiency
06/27/2012EP2468262A1 Pharmaceutical composition comprising dutasteride
06/27/2012EP2468257A2 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
06/27/2012EP2467147A1 Novel multi purpose composition
06/27/2012EP2467145A1 Compositions containing mixtures of fermentable fibers
06/27/2012EP2467140A2 Method of threating cancer
06/27/2012EP2326328B1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity
06/27/2012EP2140247B1 Method for modulating activity of t lymphocytes
06/27/2012EP2061505B1 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells
06/27/2012EP1949902B1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR
06/27/2012EP1868600B1 Spirocyclic cyclohexane derivatives for use in the treatment of substance dependency
06/27/2012EP1670449B1 Thyroid hormone analogs and methods of use in angiogenesis
06/27/2012EP1587480B1 Polyhydroxylated pyrrolizidine
06/27/2012EP1581171B1 Antibodies against gpr64 and uses thereof
06/27/2012EP1549313B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/27/2012CN1816524B Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
06/27/2012CN1678304B PKC activation as a means for enhancing aAPP-a secretion and improving cognition using bryostatin type compounds
06/27/2012CN1615155B Anti-proliferative composition
06/27/2012CN102516370A Anti-HIV (human immunodeficiency virus) medicine target and use thereof in pharmacy
06/27/2012CN102512682A Medicinal composition for treating noise-induced hearing impairment and application of medicinal composition
06/27/2012CN102512681A Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
06/27/2012CN102512680A Dosage form of Tyrosine Kinase Inhibitor for oral administration
06/27/2012CN102512679A Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an hmg coa reductase inhibitor
06/27/2012CN102512678A Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
06/27/2012CN102512677A Application of guanylate cyclase inhibitor to preparation of medicament for inhibiting myopia
06/27/2012CN102512676A Methods of using a thiazole derivative
06/27/2012CN102512667A Lipid composition of insulin, preparation method thereof, and preparation thereof
06/27/2012CN102512397A Controlled release formulations and associated methods
06/27/2012CN102512372A Pharmaceutical compositions
06/27/2012CN102512356A Intraocular drug delivery systems
06/27/2012CN102028948B Manganoporphyrin-alkylating agent combined medicine for treating tumors
06/27/2012CN101856403B Medicinal composition, preparation method thereof and pharmaceutical application
06/27/2012CN101711159B Oligo-guluronate and galacturonate compositions
06/27/2012CN101668542B Agent for treatment of pulmonary disease
06/27/2012CN101623274B Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
06/27/2012CN101485885B Protein phosphatase PPM1E used as target for treating disease as well as use thereof and siRNA
06/27/2012CN101333196B 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/27/2012CN101138550B Mixed glue bundle pharmaceutical preparations produced in combination use of multiple surfactant and processes for their preparation
06/26/2012US8207230 Functional role for cannabinoids in autonomic stability during sleep
06/26/2012US8207223 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
06/26/2012US8207212 Methods and devices for epithelial protection during photodynamic therapy
06/26/2012US8207200 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
06/26/2012US8207142 Inhibitor of DNA methylation
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8207123 Tumour-specific animal proteins
06/26/2012US8207121 Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
06/26/2012US8207118 Skin wound healing compositions and methods of use thereof
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206931 Methods of identifying modulators of cellular glycosylation using GTRAP3-18
06/26/2012US8206745 Solvent/polymer solutions as suspension vehicles
06/26/2012US8206741 Pharmaceutical compositions for the coordinated delivery of NSAIDs
06/26/2012US8206726 Zwitterionic polysaccharides for promotion of immune system maturation and health
06/26/2012US8206716 Methods of treating with anti-C5/C5a specific antibodies
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206707 Combination therapy for the treatment of ocular neovascular disorders
06/26/2012CA2669753C Therapeutic treatment of androgen receptor driven conditions
06/26/2012CA2661607C Compositions and methods for treating or preventing glaucoma or progression thereof
06/26/2012CA2526950C Method for determining immune system affecting compounds
06/26/2012CA2503211C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
06/26/2012CA2468082C Assay for screening candidate drugs for the treatment of inflammatory diseases
06/26/2012CA2443857C Bisphosphonate conjugates and methods of making and using the same
06/26/2012CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes
06/26/2012CA2426952C Small molecule compositions for binding to hsp90
06/26/2012CA2425602C Methods of high-throughput screening for internalizing antibodies
06/26/2012CA2395678C Antimicrobial compositions and methods of use
06/26/2012CA2328614C Matrices for drug delivery and methods for making and using the same
06/26/2012CA2319713C Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
06/21/2012WO2012083034A1 Modulation of neurotrophic factors by omega-3 fatty acid formulations
06/21/2012WO2012082574A1 Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides
06/21/2012WO2012081982A2 Whey protein composition with a reduced astringency
06/21/2012WO2012081971A1 Whey protein composition with a reduced astringency
06/21/2012WO2012081713A1 Therapeutic agent for blood-brain barrier disruption syndrome
06/21/2012WO2012080630A1 Novel therapeutic strategies for improving an anticancer treatment
06/21/2012WO2012012498A3 Use of trp channel agonists to treat infections
06/21/2012US20120157534 Compositions and methods of treatment for inflammatory diseases
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156182 Autogenic Living Scaffolds and Living Tissue Matrices: Methods and Uses Thereof
06/21/2012CA2821223A1 Novel therapeutic strategies for improving an anticancer treatment
06/20/2012EP2465538A2 Use of immunesuppressant receptor
06/20/2012EP2465537A1 Microspheres comprising ONO-1301
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2465513A2 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
06/20/2012EP2465509A1 Oligosaccharide composition for treating acute respiratory tract infections
06/20/2012EP2465508A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/20/2012EP2465507A1 Oligosaccharide composition for treating skin diseases
06/20/2012EP2465501A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of preparation
06/20/2012EP2465499A2 Therapeutic agent for treating pain
06/20/2012EP2465494A2 Injectable composition containing hydroxychloroquine for local administration for treating cancer
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 1151